1 to 6 of 130 results
The LUMC has developed a device for babies in the NICU who experience apnoea. Apnoea is a brief interruption in breathing, which can have dangerous consequences such as brain damage.
A research group at the Leiden Institute of Biology (IBL) has developed a new antibiotic against the pathogenic intestinal bacterium Clostridioides difficile.
Eli Lilly, one of the largest pharmaceutical companies in the world, is setting up a new factory in Katwijk, close to Leiden Bio Science Park. It is estimated that the factory will create 500 jobs for the region.
AI is developing rapidly and is influencing virtually all aspects of our society, such as research and education. However, these developments also entail risks.
The biotech company Leyden Labs from Leiden has received an investment of €30 million for their new medicine, the PanFlu nasal spray. The nasal spray offers protection against flu viruses by leaving antibodies in the nose.
The LUMC was the first in the Netherlands to perform a liver transplant using a living donor and a surgical robot. This breakthrough is a major step forward in robotic surgery and increases the chances for patients to receive a donor liver.
